Metformin inhibits mTOR signaling and tumor growth in HNSCC cells that requires the expression of organic cation transporter 3 (OCT3/SLC22A3), a Metformin uptake transporter. The gene discussed is SLC22A3; the disease is head and neck squamous cell carcinoma.